ARGENX
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
ARGENX
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2008-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.argenx.com
Total Employee:
501+
Status:
Active
Contact:
833-274-9411.
Email Addresses:
[email protected]
Total Funding:
3.75 B USD
Technology used in webpage:
IPhone / Mobile Compatible Domain Not Resolving SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Common Name Invalid ASP.NET IIS Sectigo SSL
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apeiron Biologics
Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Georgiamune
Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Oxford BioMedica
Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-11-30 | Food and Drug Administration - Priority Review Voucher | Food and Drug Administration - Priority Review Voucher acquired by argenx | 102 M USD |
Investors List
Burrage Capital
Burrage Capital investment in Post-IPO Equity - argenx
MPM Capital
MPM Capital investment in Post-IPO Equity - argenx
Dafna Capital Management
Dafna Capital Management investment in Post-IPO Equity - argenx
Aquila Capital
Aquila Capital investment in Post-IPO Equity - argenx
Erasmus MC Biomedical Fund
Erasmus MC Biomedical Fund investment in Series B - argenx
PMV
PMV investment in Series B - argenx
Omnes Capital
Omnes Capital investment in Series B - argenx
Seventure Partners
Seventure Partners investment in Series B - argenx
OrbiMed
OrbiMed investment in Series B - argenx
Forbion Capital Partners
Forbion Capital Partners investment in Series B - argenx
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-22 | OncoVerity | argenx investment in Series A - OncoVerity | 30 M USD |
| 2019-02-06 | Halozyme Therapeutics | argenx investment in Post-IPO Equity - Halozyme Therapeutics | 30 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2023-03-02 | argenx Announces Planned Transition of Chief Operating Officer |
Official Site Inspections
http://www.argenx.com Semrush global rank: 674.59 K Semrush visits lastest month: 46.44 K
- Host name: 151.101.131.10
- IP address: 151.101.131.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "argenx"
argenx | About - One Team, One Culture, One Purpose
At argenx, we build our culture from the collective power of the team and the knowledge that together, we are better. We are all co-owners of this company; we recognize that each …See details»
Company Profile - argenx Annual Report 2024
Apr 25, 2008 argenx Austria Services GmbH, incorporated under the laws of Austria, having its registered office and address at Graben 19, 4th & 5th floor Vienna A-1010 Austria. The …See details»
The argenx way
Achieving the unthinkable, together. Our culture sets us apart from other biotech companies and brings us together as one argenx. Discover what it looks like to be an argonaut.See details»
argenx | Innovation - The Science of Collaboration
The Immunology Innovation Program (IIP) is a core business strategy of argenx connecting the specialized insight into disease and target biology of our external scientific and academic …See details»
argenx - Crunchbase Company Profile & Funding
Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.See details»
argenx - 2025 Company Profile & Team - Tracxn
Jul 23, 2025 argenx is a public company based in Ghent (Belgium), founded in 2008 by Tim Van Hauwermeiren. It operates as a Developer of antibody-based drugs to treat autoimmune …See details»
Our Story - Argenx
The science of co-creation drives our quest to engineer life-changing immunology solutions, the resilient spirit of patients fuels our urgency to deliver them.See details»
Organization and Operations - argenx Annual Report 2022
Risk Factors Related to argenx’s Organization and Operations Our Future Growth and Ability to Compete Depends on Retaining our Key Personnel and Recruiting Additional Qualified …See details»
Our Pipeline - argenxmedical.com
Our pipeline starts with strong science; aimed at translating immunology breakthroughs into differentiated medicines. argenx engineers first-in-class therapies for rare diseases – where …See details»
argenx | Homepage - Reaching Patients Through Immunology …
At argenx, we’ve created an antibody innovation ecosystem where pioneering scientists and antibody engineers work side-by-side to accelerate the discovery of novel targets, disease …See details»
Investors - Argenx
At argenx, our commitment to ESG is about measuring our progress as a business based on core components that will sustain us on our path to be an integrated, immunology company.See details»
argenx | Governance
Argenx has a one-tier board consisting of executive and non-executive directors, and an executive management team responsible for the day-to-day operations of the company.See details»
argenx Reports Half Year 2025 Financial Results and Provides …
1 day ago argenx has established its strategic priorities to advance Vision 2030, aiming to treat 50,000 patients globally with its medicines, secure 10 labeled indications across all approved …See details»
Governance - argenx Annual Report 2024
Governance Introduction to Corporate Culture at argenx (ESRS 2 SBM-3, G1-1) We have put in place governance structures and mechanisms to promote accountability, adaptability, and …See details»
01. IAS 34 report HY - argenx.com
Argenx has established its strategic priorities to advance Vision 2030, aiming to treat 50,000 patients globally with its medicines, secure 10 labeled indications across all approved …See details»
argenx | Patients - Our Commitment to Patients
Argenx is proud to sponsor MG United Canada. MG United Canada was created to support Canadians living with MG and those who care for them, by providing helpful resources that …See details»
Argenx — Wikipédia
En 2008, la société Argenx, installée à Gand, est créée par trois scientifiques : Tim Van Hauwermeiren, ancien cadre d’ Ablynx et deux de ses collègues, Hans de Haard, et Torsten …See details»
Annual Report 2022 | argenx – Home
Read the entire argenx Annual Report 2022 online – the financial year, corporate governance, patient stories and much more.See details»
Ethics and Responsibility - Argenx
Written Standards argenx has established policies and procedures, including our Code of Business Conduct and Ethics, which articulate our fundamental principles and values and …See details»
argenx Reports Half Year 2025 Financial Results and Provides …
1 day ago Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe …See details»